Abstract
Global brain state dynamics regulate plasticity in local cortical circuits, but the underlying cellular and molecular mechanisms are unclear. Here, we demonstrate that astrocyte Ca(2+) signaling provides a critical bridge between cholinergic activation, associated with attention and vigilance states, and somatosensory plasticity in mouse barrel cortex in vivo. We investigated first whether a combined stimulation of mouse whiskers and the nucleus basalis of Meynert (NBM), the principal source of cholinergic innervation to the cortex, leads to enhanced whisker-evoked local field potential. This plasticity is dependent on muscarinic acetylcholine receptors (mAChR) and N-methyl-d-aspartic acid receptors (NMDARs). During the induction of this synaptic plasticity, we find that astrocytic [Ca(2+)](i) is pronouncedly elevated, which is blocked by mAChR antagonists. The elevation of astrocytic [Ca(2+)](i) is crucial in this type of synaptic plasticity, as the plasticity could not be induced in inositol-1,4,5-trisphosphate receptor type 2 knock-out (IP(3)R2-KO) mice, in which astrocytic [Ca(2+)](i) surges are diminished. Moreover, NBM stimulation led to a significant increase in the extracellular concentration of the NMDAR coagonist d-serine in wild-type mice when compared to IP(3)R2-KO mice. Finally, plasticity in IP(3)R2-KO mice could be rescued by externally supplying d-serine. Our data present coherent lines of in vivo evidence for astrocytic involvement in cortical plasticity. These findings suggest an unexpected role of astrocytes as a gate for cholinergic plasticity in the cortex.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholine / pharmacology
-
Action Potentials / drug effects
-
Action Potentials / genetics
-
Afferent Pathways / physiology
-
Aniline Compounds / metabolism
-
Animals
-
Astrocytes / drug effects
-
Astrocytes / physiology*
-
Atropine / pharmacology
-
Basal Nucleus of Meynert / physiology*
-
Calcium Signaling / drug effects
-
Calcium Signaling / genetics
-
Calcium Signaling / physiology*
-
Cholinergic Agents / metabolism*
-
Chromatography, High Pressure Liquid
-
Evoked Potentials, Somatosensory / drug effects
-
Evoked Potentials, Somatosensory / genetics
-
Excitatory Amino Acid Antagonists / pharmacology
-
Fluoresceins / metabolism
-
Inositol 1,4,5-Trisphosphate Receptors / deficiency
-
Male
-
Mice
-
Mice, Knockout
-
Microdialysis / methods
-
Muscarinic Antagonists / pharmacology
-
Nerve Growth Factors / metabolism
-
Neuronal Plasticity / drug effects
-
Neuronal Plasticity / genetics
-
Neuronal Plasticity / physiology*
-
Neurons / drug effects
-
Neurons / metabolism
-
Physical Stimulation
-
Piperazines / pharmacology
-
S100 Calcium Binding Protein beta Subunit
-
S100 Proteins / metabolism
-
Serine / pharmacology
-
Somatosensory Cortex / drug effects
-
Somatosensory Cortex / physiology*
-
Sulfonamides / metabolism
-
Thiazoles / metabolism
-
Vibrissae / innervation
Substances
-
Aniline Compounds
-
Cholinergic Agents
-
Excitatory Amino Acid Antagonists
-
Fluoresceins
-
Inositol 1,4,5-Trisphosphate Receptors
-
Muscarinic Antagonists
-
Nerve Growth Factors
-
Oregon green 488 BAPTA-1
-
Piperazines
-
S100 Calcium Binding Protein beta Subunit
-
S100 Proteins
-
SR1001
-
Sulfonamides
-
Thiazoles
-
Serine
-
Atropine
-
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
-
Acetylcholine